Ovarian Diseases  >>  goserelin acetate  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
goserelin acetate / Generic mfg.
NCT00012090: Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum

Completed
2
US
bicalutamide, goserelin acetate
Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
04/04
04/04
NCT00196846 / 2004-003980-62: Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)

Completed
2
62
Europe
Goserelin
German Breast Group
Breast Cancer
12/08
03/10

Download Options